News in the Life Sciences Industry

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) reports today that the ninth and final patient was recruited to the phase Ia study of MIV-818 in patients with advanced liver cancer. Based on data from phase Ia, the initial dose of MIV-818 for the phase Ib... Read more ››

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Scandinavian ChemoTech and its CEO Mohan Frick has been selected to present its Tumour Specific Electroporation at the Emerging Medtech Summit in California, USA. An event bringing together the top strategists, investors, and innovators within the... Read more ››

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Today, 18th November 2019, RhoVac AB ("RhoVac") reports interim results from ongoing immunological studies at University of Tübingen, Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells.

STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- KRY/LIVI takes a new and important step to revolutionise healthcare by introducing seamless digi-physical services in the south of Sweden. A new physical centre opens in Malmö to complement the KRY app. This new approach will fill the gap between digital... Read more ››

STOCKHOLM, Nov. 15, 2019 /PRNewswire/ -- Cantargia AB announced today that the pre-IND meeting regarding the clinical development of antibody CAN04 was held with the US FDA. The purpose of the meeting was to discuss the available information on CAN04, including data from the first-in-human... Read more ››

HUDDINGE, Sweden, Nov. 15, 2019 /PRNewswire/ --

STOCKHOLM, Nov. 15, 2019 /PRNewswire/ -- Cantargia AB's ("Cantargia") interim report for the period January until September 2019 is now available on the company's web page Read more ››

SUNDSVALL, Sweden, Nov. 15, 2019 /PRNewswire/ -- Permobil launches the most advanced wheelchair power assist system on the global market. A gesture-controlled smartwatch app enables users to simply tap the wheel to control the powerful SmartDrive MX2+ motor via Bluetooth. Steep slopes and uneven... Read more ››

STOCKHOLM, Nov. 14, 2019 /PRNewswire/ -- "This third quarter of 2019 saw us move steadily towards full recruitment of the NefIgArd study, despite a somewhat slower pace during the summer months. We can now see the finish line and we hope that the next couple of months develop as planned so that... Read more ››

STOCKHOLM, Nov. 14, 2019 /PRNewswire/ -- "Following a record first half year, sales weakened in the third quarter. However, the market situation and demand for our products remain favorable and we have confidence in our strategy"

STOCKHOLM, Nov. 14, 2019 /PRNewswire/ -- "Since the US is the world's largest market for neurosurgical procedures, we have focused much of our team's resources toward supporting a successful early market introduction. Response to our IRRAflow technology remains strong, and our sales funnel... Read more ››

STOCKHOLM, Nov. 14, 2019 /PRNewswire/ -- The shareholders in Oncopeptides AB (publ), reg. no. 556596-6438, with registered office in the municipality of Stockholm, ("Oncopeptides" or the "Company") are hereby given notice to attend an Extraordinary General Meeting to be held at Tändstickspalatset,... Read more ››